DEANNA SCHLEGEL: Open Payments
NPI 1245966597 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$794 in 20 payments from 9 companies in 2025. Trend: 2023 $66 · 2024 $96 · 2025 $794
Food & beverage: $794
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $224 |
| Bioventus LLC | 2 | $175 |
| BIOTRONIK NRO, Inc. | 1 | $150 |
| Ipsen Biopharmaceuticals, Inc | 2 | $58 |
| Medtronic, Inc. | 2 | $55 |
| MML US, Inc. | 1 | $52 |
| PFIZER INC. | 2 | $40 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $27 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: DUROLANE, Prospera, BOTOX, QULIPTA, Dysport, ReActiv8, NURTEC ODT, KYPHON EXPRESS II KYPHOPAK TRAY.
Industry payments across OR — which companies pay providers there.
